- Spring Senior Executives Conference
May 1, 2022 - May 3, 2022
5:00 pm - 9:30 am EST
The Spring Senior Executive Conference is one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each conference focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.
This conference will focus on cell and gene therapies. Cell and gene therapies (CGT) are a transformative new category of medicines whose full potential is beginning to emerge. The ability to address complex diseases, as well as many rare disorders for which there are no effective treatments, makes CGT poised to transform the pharmaceutical and biotech industry.
There is little doubt that cell and gene therapies are a promising new segment, but market entry is not straightforward, and established pharma & biotech companies must develop new strategies to enter the market and become respected players. What role can ALDA member companies play in this expanding field? How did we get to where we are, and what’s coming next? Join your ALDA colleagues as we explore the CGT impact on our industry moving forward.
As always, this intimate event is for C-suite and senior executives from our member companies. If you have questions about who should attend this event please contact Carol Starke (firstname.lastname@example.org).
Sunday, May 1, 2022
6:00-9:00 PM Opening Reception & Dinner
New York Times Best-Selling Author and Professor,
Stanford Graduate School of Business
ALDA events typically kick off with a business-oriented speaker at the opening dinner; this event is no exception. Chip Heath is a professor at Stanford Graduate School of Business, teaching courses on business strategy and organizations. Chip’s latest book Making Numbers Count was just released on January 11 and joins his other books on the New York Times and Wall Street Journal best seller lists: The Power of Moments, Decisive, Switch, and Made to Stick. Chip will share relevant, impactful findings and takeaways from his work with ALDA attendees.
Monday, May 2, 2022
9:00 AM to 4:15 PM General Sessions
Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine
University of Pennsylvania
Renowned cancer immunologist Carl June wears many hats and holds many titles, including pioneer of Chimeric Antigen Receptor T (CAR-T) cells, Perelman School of Medicine tenured professor and one of Time Magazine’s 100 most influential people of 2018. Dr. June will lead off our CGT programming by providing an overview of the decades of research that have gone into his incredible advancements and therapies, and also paint the picture of what else is being researched and developed in this area and what’s to come.
Pharma Perspective on CGT
Stefan Wildt, Ph.D.
Chief Technology Officer, R&D
Stefan Wildt will dive into what is currently taking place, what’s next, and what’s needed from the customer’s perspective. How is pharma looking at the next phases of these exciting therapies, and what types of sophisticated tools will be needed to navigate the complex research, development, and commercial phases to further advance this promising science?
Financial Overview of CGT Market
Two financial analysts from Morgan Stanley, well-versed in the CGT market, will discuss trends and opportunities for tools companies in this space.
Managing Director, Investment Banking Division
Managing Director, Healthcare Investment Banking
Topic-based small group discussions, chosen by attendees in advance of the conference
Senior Executive Panel: Dynamic CGT Tools Companies
CEOs of tools companies in this space will discuss their status as well as their plans in the years ahead. Confirmed speakers include:
* Doug Doerfler, President & CEO, MaxCyte
* Stephen Gunstream, President & CEO. Teknova
* Sean Mackay, CEO & Co-Founder, IsoPlexis
* Aby J. Mathew, Senior Vice President & CSO, Biolife Solutions
Managing Director, Investment Banking Division
Tuesday, May 3, 2022
8:00-9:15 AM Understanding Risk & Mastering the Unknown
Stanley A. McChrystal
Retired four-star general
A retired four-star general, General McChrystal is the former commander of US and International Security Assistance Forces (ISAF) Afghanistan and the former commander of the nation’s premier military counter-terrorism force, Joint Special Operations Command (JSOC). He is best known for developing and implementing a comprehensive counterinsurgency strategy in Afghanistan, and for creating a cohesive counter-terrorism organization that revolutionized the interagency operating culture. General McChrystal is a senior fellow at Yale University’s Jackson Institute for Global Affairs, where he teaches a course on Leadership. General McChrystal is also a best-selling author including Team of Teams: New Rules of Engagement for a Complex World which he will discuss along with his latest, Risk: A User’s Guide. All attendees will also receive a copy of his latest book. The fireside chat style session will also provide an opportunity for attendees to ask questions of General McChrystal.
The health and safety of our members and attendees has been and will continue to be our top priority. We will continue to monitor and work with the Mandarin Oriental to make sure protocols are in place at the hotel to execute a safe event, as well as monitor and make you aware of any travel requirements needed to attend the event in-person, especially for those traveling from Europe or other international locations. Attendees can expect at least the level of safety experienced at our October conference in Laguna Beach, to ensure that the event delivers the high level of quality expected from an ALDA conference.
See you in Boston!
**REGISTRATION CANCELLATION POLICY: No refunds of meeting registration fees will be made for registration cancellations after Wednesday, April 20.